StockWatch
·
Pharmaceutical Preparations
AcquisitionsJun 18, 2026, 04:12 PM

Vireo Growth to Acquire C21 Investments for 0.023052 Shares

AI Summary

Vireo Growth Inc. announced a definitive arrangement agreement to acquire C21 Investments Inc. for 0.023052 subordinate voting shares of Vireo per C21 share. This acquisition is expected to significantly expand Vireo's footprint in Nevada, adding approximately 15 dispensaries and substantial cultivation/manufacturing capacity. The transaction has received unanimous approval from the C21 Board and is supported by C21's directors and executive officers through voting agreements. Completion is contingent upon C21 shareholder approval, court and regulatory approvals, and other customary closing conditions. C21 will delist from exchanges upon completion.

Key Highlights

  • Vireo Growth Inc. to acquire all issued and outstanding common shares of C21 Investments Inc.
  • The exchange ratio is 0.023052 subordinate voting shares of Vireo for each C21 share.
  • Acquisition expected to broaden Vireo's presence in Nevada to approximately 15 dispensaries.
  • C21's directors and executive officers have entered into voting and support agreements for the arrangement.
  • Completion is subject to C21 shareholder approval, court orders, and regulatory approvals.
  • C21 may be required to pay Vireo a termination fee of $3,000,000 under certain circumstances.